Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The study record for a completed trial of recombinant EphB4-HSA and pembrolizumab is available, including its design, participation criteria, outcome measures, and results-related information.
    Difference
    66%
    Check dated 2026-11-07T15:14:03.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T16:01:44.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates about the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The clinical trial page still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-24T18:10:38.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:45.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer now lists revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T21:52:41.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the previous study details with an error screen. This indicates an access restriction rather than an update to the trial content.
    Difference
    21%
    Check dated 2026-09-19T21:01:26.000Z thumbnail image

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.